Klotho Neurosciences, Inc. financial data

Symbol
KLTO, KLTOW on Nasdaq
Location
1115 Broadway, 12 Th Floor, New York, NY
Fiscal year end
December 31
Former names
ANEW Medical, Inc. (to 9/18/2024), Redwoods Acquisition Corp. (to 6/21/2024)
Latest financial report
10-Q - Q3 2024 - Nov 19, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 19.2 % +952%
Debt-to-equity -221 % +64.3%
Return On Equity 202 %
Return On Assets -53.2 % -3386%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 21.3M shares +142%
Common Stock, Shares, Outstanding 19.9M shares +483%
Common Stock, Value, Issued 1.99K USD +484%
Weighted Average Number of Shares Outstanding, Basic 16.7M shares +10.3%
Weighted Average Number of Shares Outstanding, Diluted 16.7M shares +10.3%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 0 USD
General and Administrative Expense 3.24M USD +536%
Operating Income (Loss) -4.22M USD -352%
Nonoperating Income (Expense) -88.5K USD -334%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.42M USD -1954%
Income Tax Expense (Benefit) 484K USD -80.8%
Net Income (Loss) Attributable to Parent -3.66M USD -356%
Earnings Per Share, Basic -0.18 USD/shares -1700%
Earnings Per Share, Diluted -0.18 USD/shares -1700%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 50.9K USD -65.2%
Assets, Current 155K USD -24.1%
Intangible Assets, Net (Excluding Goodwill) 2.31M USD
Other Assets, Noncurrent 2.31M USD
Assets 2.46M USD -95.8%
Accounts Payable, Current 271K USD
Accrued Liabilities, Current 560K USD +71%
Liabilities, Current 982K USD -41%
Deferred Income Tax Liabilities, Net 18.1K USD
Liabilities 1M USD -86.1%
Retained Earnings (Accumulated Deficit) -8.5M USD -32%
Stockholders' Equity Attributable to Parent 1.46M USD +109%
Liabilities and Equity 2.46M USD -95.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -377K USD -0.95%
Net Cash Provided by (Used in) Financing Activities 282K USD -44.7%
Net Cash Provided by (Used in) Investing Activities -70K USD +80.6%
Common Stock, Shares Authorized 1B shares +1900%
Common Stock, Shares, Issued 19.9M shares +483%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 50.9K USD +2277%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares
Additional Paid in Capital 9.65M USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 1.95M USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares